Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Carcinogenesis|July 18, 2008
MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expressionMagda A Meester-Smoor, Marjolein J F W Janssen, Gerard C Grosveld, et al.
Cancer Research|March 18, 2004
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinomaBas W G van Rhijn, Theo H van der Kwast, André N Vis, et al.
The Journal of Urology|December 4, 2012
Combinations of urinary biomarkers for surveillance of patients with incident nonmuscle invasive bladder cancer: the European FP7 UROMOL projectTahlita C M Zuiverloon, Willemien Beukers, Kirstin A van der Keur, et al.
The Journal of Urology|November 13, 2012
FGFR3 mutation analysis in voided urine samples to decrease cystoscopies and cost in nonmuscle invasive bladder cancer surveillance: a comparison of 3 strategiesKim E M van Kessel, Lucie C Kompier, Esther W de Bekker-Grob, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2012
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNADaniëlle A M Heideman, Irene Lurkin, Marije Doeleman, et al.
The Journal of Pathology|December 15, 2005
Lack of genetic and epigenetic changes in meningiomas without NF2 lossAngela A G van Tilborg, Bruno Morolli, Micheline Giphart-Gassler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urineBas W G van Rhijn, Irene Lurkin, Dominique K Chopin, et al.
BMC Urology|March 2, 2010
In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case reportTahlita C M Zuiverloon, Cheno S Abas, Kirstin A van der Keur, et al.
Oncology Letters|January 2, 2016
Positive fibroblast growth factor receptor 3 immunoreactivity is associated with low-grade non-invasive urothelial bladder cancerCédric Poyet, Thomas Hermanns, Qing Zhong, et al.
Urologic Oncology|February 15, 2020
Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic reviewThomas van Doeveren, Harmen J G van de Werken, Job van Riet, et al.
Pageof 12